Shu Ning

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer”.

Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0015

N/A

0DataRank · unranked

82 citations

Shu Ning, Wei Lou, Joy C. Yang, Cameron M. Armstrong, Alan P. Lombard +5 more

Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models

Pharmacological Research(2023)10.1016/j.phrs.2023.106692

N/A

0DataRank · unranked

22 citations

Joy C. Yang, Shu Ning, Bo Chen, Christopher Nip, Qiang Wei +7 more

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer

Oncogene(2023)10.1038/s41388-022-02566-6

N/A

0DataRank · unranked

21 citations

Pengfei Xu, Shu Ning, Logan J. Wasielewski, Hans Adomat, Sung Hee Hwang +9 more

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

Nature Communications(2024)10.1038/s41467-024-50459-x

N/A

0DataRank · unranked

10 citations

Joy C. Yang, Bo Chen, Shu Ning, Xiong Zhang, Leyi Wang +16 more

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

Oncogene(2024)10.1038/s41388-024-03081-6

N/A

0DataRank · unranked

5 citations

Pengfei Xu, Joy C. Yang, Christopher Nip, Leyi Wang, Yuqiu Shen +9 more

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

Research Square(2024)10.21203/rs.3.rs-4095949/v1

N/A

0DataRank · unranked

0 citations

Bo Chen, Pengfei Xu, Joy C. Yang, Christopher Nip, Leyi Wang +9 more